The pediatric medicines market size has the potential to grow by USD 27.71 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by type (respiratory diseases, infectious diseases, gastrointestinal diseases, CNS diseases, oncological diseases, and others), RoA (enteral, parenteral, and topical), and geographic landscape (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd.
What will be the Pediatric Medicines Market Size in 2020?
Browse TOC and LoE with selected illustrations and example pages of Pediatric Medicines Market
Who are the Major Pediatric Medicine Vendors?
The pediatric medicines market is fragmented. Market vendors are partnering with research organizations and hospitals for R&D and are participating in various scientific conferences to showcase their products. AbbVie Inc., Bayer AG, and F. Hoffmann-La Roche Ltd. are some of the major market participants. Although formulatory advancement will offer immense growth opportunities, the high use of off-label drugs will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this pediatric medicines market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this pediatric medicines market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
- AbbVie Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Takeda Pharmaceutical Co. Ltd.
Which are the Key Markets for Pediatric Medicines?
For more insights on the market share of various regions Request for a FREE sample now!
North America was the largest pediatric medicines market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The sales of drugs used to treat various pediatric conditions and deteriorating environmental conditions that add to the prevalence of several medical conditions, including pediatric disorders and associated risk factors will significantly drive pediatric medicines market growth in this region over the forecast period.
Over 41% of the market’s growth will originate from North America during the forecast period. The US is a key market for pediatric medicines market in North America. Market growth in this region will be faster than the growth of the market in Europe.
What are the Major Type Segments in the Pediatric Medicines Market?
Request for a FREE sample and Get more information on the market contribution of various segments
Respiratory diseases are the most common type of disease observed among people. The prevalence of these diseases is higher in under-developed and developing economies compared with developed nations. This segment is expected to grow due to the rising prevalence of asthma in children. This report provides an accurate prediction of the contribution of all the segments to the growth of the pediatric medicines market size.
How will Formulatory Advancement Influence Pediatric Medicines Market Growth?
Formulatory advancements will have a significant influence on the growth of this market. Vendors in the therapeutics market are focusing on convenience in dosing, better administration, better bioavailability, improved efficacy, and reduced side effects. Reformulation of pediatric product development results in improved efficacy and extended delivery of therapy, which consequently, results in the acceptance of medicines among the pediatric population.
The vendors in the market are continuously on the lookout for strategic alliances and acquisitions that help in geographical expansion and impressive product line extension. These inorganic growth strategies result in technological advances due to mutual collaboration in R&D and improved product portfolio. Such growth strategies will be one of the key trends influencing the growth of the pediatric medicines market. As a result of such factors, the market will register a CAGR of 5% during the forecast period.
Request for a FREE sample now!
What are the Key Factors Covered in this Pediatric Medicines Market Report?
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will drive pediatric medicines market growth during the next five years
- Precise estimation of the pediatric medicines market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the pediatric medicines industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of pediatric medicines market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch